The North America preoperative infection prevention & wound cleansing device market is expected to grow from US$ 798.48 million in 2021 to US$ 1,256.00 million by 2028. It is estimated to record a CAGR of 6.7% from 2021 to 2028.

Increasing Incidence of Hospital Acquired Infections Drives North America Preoperative Infection Prevention & Wound Cleansing Device Market Growth

Healthcare facilities in several countries a high risk of infection to patients. In hospitals, infections cause unnecessary suffering and the death of millions of patients every year. According to the Centers for Disease Control and Prevention (CDC), in the US, ~1 in 31 patients in hospitals suffers from at least one HAIs on any given day. According to the data provided by PatientCareLink, in American Hospitals alone, HAIs account for an estimated 1.7 million infection cases and 99,000 associated diseases each year, out of which 22% are surgical site infections. Healthcare facilities in low and middle-income countries have exceptionally high HAI rates, possibly due to the additional challenges in achieving effective infection control, lack of cleanliness in hospitals, and lack of awareness regarding infection control. Seriously ill patients are highly susceptible to HAIs in industrialized and developing countries. An increase in HAI cases fuels the need for preoperative infection prevention devices, driving the North America preoperative infection prevention & wound cleansing devices market growth.

North America Preoperative Infection Prevention & Wound Cleansing Device Market Overview

The North America preoperative infection prevention & wound cleansing device market is segmented into the US, Canada, and Mexico. The North America preoperative infection prevention & wound cleansing device market growth is attributed to the rise in surgical procedures, increase in the R&D activities initiated by the government, and the surge in the geriatric population in the region. The surgical site infection control market has been dominated by North America, with the US accounting for the largest share of regional revenue. Surgical Site Infections (SSIs) are the most common healthcare-associated infection (HAI) among patients in acute care hospitals in the US (tied with pneumonia). According to the Centers for Disease Control and Prevention, Healthcare-Acquired Infections Progress Report 2020, nearly 18,416 surgical site infections were reported in 2020 in the US. Such a high surgical site infection rate creates the need for surgical site infection products and thus propels the growth of the market. Thus, the surging number of hospital admissions is expected to increase the cases of surgical site infection, thereby boosting the North America preoperative infection prevention & wound cleansing device market.

North America Preoperative Infection Prevention & Wound Cleansing Device Market Revenue and Forecast to 2028 (US$ Billion)

North America Preoperative Infection Prevention & Wound Cleansing Device Market Segmentation

The North America preoperative infection prevention & wound cleansing device market is segmented on the basis of product, surgery, application, and country.

Based on product, the North America preoperative infection prevention & wound cleansing device market is bifurcated into preoperative infection prevention devices and preoperative wound cleansing devices. In 2021, the preoperative infection prevention devices segment registered a larger share in the North America preoperative infection prevention & wound cleansing device market. The market for the preoperative infection prevention devices segment is further segmented into infection prevention supplies, medical waste disposable devices, and infection prevention equipment.

Based on surgery, the North America preoperative infection prevention & wound cleansing device market is segmented into cataract surgery, cesarean surgery, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, and others. In 2021, the cosmetic surgery segment registered the largest share in the North America preoperative infection prevention & wound cleansing device market.

Based on application, the North America preoperative infection prevention & wound cleansing device market is segmented into preoperative hair removal, preoperative skin preparation, intraoperative wound irrigation solution, and others. In 2021, the preoperative hair removal segment registered the largest share in the North America preoperative infection prevention & wound cleansing device market. The preoperative hair removal segment is further sub segmented into clippers, razors, and depilators. The market for the preoperative skin preparation segment is further segmented into single use and multiple use. The market for the intraoperative wound irrigation solution segment is sub segmented into detergents, antibiotic laden lavage, antiseptic agents, and sterile normal saline market.

Based on country, the North America preoperative infection prevention & wound cleansing device market is segmented into the US, Canada, and Mexico. In 2021, the US segment registered the largest share in the North America preoperative infection prevention & wound cleansing device market.

3M Co, Bactiguard AB, Becton Dickinson and Co, bioMerieux SA, Cardinal Health Inc, Dynarex Corp, Getinge AB, Medline Industries Inc, and Steris Plc are among the leading companies operating in the North America preoperative infection prevention & wound cleansing device market.